Trial Profile
Phase I pharmacokinetic trial of topical ketoprofen [Impracor; Imprimis Pharmaceuticals].
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary) ; Ketoprofen (Primary)
- Indications Musculoskeletal pain
- Focus Pharmacokinetics
- 21 Feb 2013 New trial record
- 19 Feb 2013 Results have been reported in an Imprimis Pharmaceuticals media release.
- 19 Feb 2013 The trial has been completed according to an Imprimis Pharmaceuticals media release.